XML 36 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS
 12 Months Ended
Dec. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS
Venture capital investments are summarized below:
December 30, 2023December 31, 2022December 25, 2021
(in thousands)
Beginning balance$129,012 $149,640 $197,100 
Capital contributions17,410 14,485 18,023 
Distributions(15,685)(9,861)(40,205)
Gain (loss)(10,263)(24,398)(23,201)
Foreign currency translation684 (854)(2,077)
Ending balance$121,158 $129,012 $149,640 
The Company also invests, with minority positions, directly in equity of predominantly privately-held companies. Strategic investments are summarized below:
December 30, 2023December 31, 2022December 25, 2021
(in thousands)
Beginning balance$182,590 $51,712 $24,704 
Purchase of investments34,028 142,477 35,540 
Distributions(9,381)(2,732)(789)
Gain (loss) (1)
108,090 (2,377)(7,219)
Reduction for acquisition of entities (1)
(197,753)— — 
Foreign currency translation5,079 (6,490)(524)
Ending balance$122,653 $182,590 $51,712 
(1) Refer to Note 2. Acquisitions for further discussion on the Noveprim and SAMDI acquisitions